Compare Cronos Group Inc (CRON) vs Norwegian Cruise Line Holdings Ltd (NCLH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cronos Group Inc vs Norwegian Cruise Line Holdings Ltd — how do they compare? Cronos Group Inc trades at $3.06 (market cap $1.14B), while Norwegian Cruise Line Holdings Ltd trades at $18.71 (market cap $8.59B). The key difference: Norwegian Cruise Line Holdings Ltd is far larger — about 7.5× Cronos Group Inc's market cap, and Cronos Group Inc is trading nearer its 52-week high, Norwegian Cruise Line Holdings Ltd nearer its low. Which is the better fit depends on your goals.
| CRON | NCLH | |
|---|---|---|
Market Cap | $1.14B | $8.59B |
Sector | Health | Consumer Cyclical |
52-Week High | $3.27 | $26.94 |
52-Week Low | $2.30 | $14.79 |
Enterprise Value | $341.13M | $23.40B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CRON trades at $3.00, down 3.23% today, with a bullish technical signal from moving averages. The company showed strong Q2 2026 performance with 58% YoY revenue growth and earnings beat, though recent quarters were mixed. Valuation metrics include P/E of 16.21 and P/S of 6.55, while profitability improved with 45.86% gross margin. Analyst consensus is mixed with 20% buy, 60% hold ratings.
Outlook remains positive due to international expansion and strong product positioning, particularly in Canada and Europe. Key risks include competitive pressures and cash flow volatility from aggressive investing. The stock presents growth potential but requires monitoring of execution and market conditions.
NCLH trades at $18.55, down 3.64% today, amid a bearish technical signal. The company reported Q2 2026 EPS of $0.48, beating estimates, but faces headwinds from high fuel costs and soft demand. Revenue growth is steady, with 2025 revenue at $9.83B, and profitability metrics like a 7.49% net income margin show resilience. Analyst consensus is bullish with a $20.73 price target, though recent news highlights execution risks and macroeconomic pressures.
The outlook is mixed: strong fundamentals and analyst support suggest upside potential, but near-term volatility from cost pressures and travel demand uncertainty poses risks. Investors should weigh the attractive valuation against operational challenges in the cruise industry.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cronos Group Inc
Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.
Read more on CRON →About Norwegian Cruise Line Holdings Ltd
Norwegian Cruise Line is the world's third-largest cruise company by berths (at more than 62,000), operating 29 ships across three brands (Norwegian, Oceania, and Regent Seven Seas), offering both freestyle and luxury cruising. The company has redeployed its entire fleet as of May 2022. With eight passenger vessels on order among its brands through 2027 (representing 20,000 incremental berths), Norwegian is increasing capacity faster than its peers, expanding its brand globally. Norwegian sailed to around 500 global destinations before the pandemic.
Read more on NCLH →
